This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Heraeus Parts Ways With Dental Business

HANAU, Germany, April 4, 2013 /PRNewswire/ --

Heraeus, the Hanau-based precious metals and technology Group, is parting ways with its dental business. The entire business group will be acquired by Mitsui, a listed chemicals group with 13,000 employees worldwide. The acquisition is still subject to the approval of the antitrust authorities.

Heraeus Dental ranks among the top providers of dental solutions and materials, including precious metal alloys and materials for prosthetic treatments, teeth and materials for full prosthetic treatments, casting materials and compounds used for local anesthesia. Heraeus Dental has a total of 1,400 employees around the world. It reported revenues of €360 million for 2012. Customers include dentists and dental technicians as well as others in the dental field.

The introduction of new materials and treatments has fundamentally changed the Heraeus Dental business in recent years. In particular, the use of precious metals products, Heraeus' traditional core business, has dropped dramatically in dental medicine.

Heraeus Dental responded to market demands by instituting efficiency programs. Besides, the business group expanded its activities in the business segment of digital prosthetics. Heraeus Dental is operating at a profit and well positioned for its future development.

However, given the fundamental changes in this business area Heraeus has decided to sell the business group after a portfolio evaluation. Mitsui plans to expand its activities in this business area, which will give Heraeus Dental promising opportunities for development. "We see very good opportunities for long-term development for Heraeus Dental in this new constellation. This was a crucial factor for us in the decision to sell," said Jan Rinnert, Heraeus Board of Management.

Mitsui intends to retain all the employees of the 20 worldwide locations with its acquisition of the business group. Heraeus Dental's existing management will remain intact and will continue the company's operations. Mitsui supports the current strategy of Heraeus Dental and intends to continue it. At this point in time, no further job cuts are planned beyond the measures that were introduced this past year. The headquarters of Heraeus Dental managing company Heraeus Kulzer GmbH will remain in Hanau.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,061.81 +11.06 0.06%
S&P 500 2,013.43 +15.91 0.80%
NASDAQ 4,828.4630 +17.6750 0.37%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs